Abivax Patents – Insights & Stats (Updated 2023)

Abivax has a total of 52 patents globally, out of which 16 have been granted. Of these 52 patents, more than 40% patents are active. Europe is where Abivax has filed the maximum number of patents, followed by Canada and India. Parallelly, Europe seems to be the main focused R&D centre and also France is the origin country of Abivax.

Abivax was founded in 2013. Abivax is a biotechnology company in the clinical stages. The company’s primary goal is to create medicines that target the immune system in patients with long-term inflammatory conditions by using the body’s built-in regulatory systems.

Do read about some of the most popular patents of Abivax which have been covered by us in this article and also you can find Abivax patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Abivax patent portfolio.

How many patents does Abivax have?

Abivax has a total of 52 patents globally. These patents belong to 18 unique patent families. Out of 52 patents, 52 patents are active.

How Many Patents did Abivax File Every Year?

Abivax Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAbivax Applications FiledAbivax Patents Granted
202212
20213
20202
20192
20181
201772
20151
201422
201352
20122
20117

How many Abivax patents are Alive/Dead?

Worldwide Patents

Abivax Patent Portfolio

How Many Patents did Abivax File in Different Countries?

Abivax Worldwide Patent Filing

Countries in which Abivax Filed Patents

CountryPatent
Europe10
Canada8
India3
Portugal2
Brazil2
South Africa2
Argentina2
Denmark1
Poland1
Norway1
Spain1
Germany1
Australia1
Austria1
Italy1

Where are Research Centers of Abivax Patents Located?

R&D Centres of Abivax

10 Best Abivax Patents

WO2012080953A1 is the most popular patent in the Abivax portfolio. It has received 55 citations so far from companies.

Below is the list of 10 most cited patents of Abivax:

Publication NumberCitation Count
WO2012080953A155
WO2015001518A151
EP2465502A147
WO2014111892A126
EP2757161A125
WO2010040710A121
EP2266972A116
EP1712634A15
WO2014049578A15
EP2058011A14

What are Abivax key innovation segments?

What Technologies are Covered by Abivax?

The chart below distributes patents filed by Abivax in different countries on the basis of the technology protected in patents. It also represents the markets where Abivax thinks it’s important to protect particular technology inventions.

R&D Focus: How has Abivax search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Abivax?

Related Articles

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.